Novo cuts 400 jobs in Indiana as Scholar Rock refiles drug linked to the factorynews2026-04-01T16:39:35+00:00April 1st, 2026|Endpoints News|
Eli Lilly wins approval of anti-obesity pill orforglipronnews2026-04-01T15:41:36+00:00April 1st, 2026|Endpoints News|
Pharma goes on $25.5B, eight-day acquisition spreenews2026-03-31T19:32:28+00:00March 31st, 2026|Endpoints News|
FDA identifies eight deaths tied to Amgen’s Tavneosnews2026-03-31T19:13:11+00:00March 31st, 2026|Endpoints News|
Novo Nordisk launches subscription program for Wegovy drugsnews2026-03-31T11:46:56+00:00March 31st, 2026|Endpoints News|
Eli Lilly to buy Centessa for $6.3B to get sleep disorder drugnews2026-03-31T11:04:34+00:00March 31st, 2026|Endpoints News|
#ACC26: Merck touts comparator data for oral cholesterol drugnews2026-03-30T18:33:20+00:00March 30th, 2026|Endpoints News|
Drugmakers skeptical of new White House overtures on pricingnews2026-03-30T17:58:06+00:00March 30th, 2026|Endpoints News|
#ACC26: Merck leans toward lower Winrevair dose in Phase 3 trial for rare form of heart failurenews2026-03-29T16:00:49+00:00March 29th, 2026|Endpoints News|
Otsuka buys Transcend Therapeutics for $700M upfrontnews2026-03-27T18:21:02+00:00March 27th, 2026|Endpoints News|
